Minimizing control group allocation in randomized trials using dynamic borrowing of external control data – An application to second line therapy for non-small cell lung cancer-Reference-Cited by-同舟云学术

Minimizing control group allocation in randomized trials using dynamic borrowing of external control data – An application to second line therapy for non-small cell lung cancer

Published:2019-12 Issue: Volume:16 Page:100446
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Dron Louis,Golchi Shirin,Hsu Grace^ORCID,Thorlund Kristian

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference16 articles.

1. Innovative research methods for studying treatments for rare diseases: methodological review;Gagne,2014

2. Rare cancer trial design: lessons from FDA approvals;Gaddipati;Clin. Cancer Res.,2012

3. The ethics of clinical trials;Nardini;Ecancermedicalscience,2014

4. Report on General Perceptions and Knowledge on Clinical Research;CISCRP,2017

5. The national academies collection: reports funded by National Institutes of Health;NAo,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Augmenting external control arms using Bayesian borrowing: a case study in first-line non-small cell lung cancer;Journal of Comparative Effectiveness Research;2024-05

2. Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials;Journal of Clinical Oncology;2024-04-20

3. Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology Trials;JCO Precision Oncology;2024-02

4. Use of external control arms in immune-mediated inflammatory diseases: a systematic review;BMJ Open;2023-12

5. Review article: Externally derived control arms—An opportunity for clinical trials in inflammatory bowel disease?;Alimentary Pharmacology & Therapeutics;2023-08-21